Glenmark Pharmaceuticals

More Stories on Glenmark Pharmaceuticals

Jio Financial, Glenmark Pharma, GodrejCP, Gujarat Ambuja: How to trade these buzzing stock

Dec 26, 2025, 07:49 AM IST

Choice Broking said that Jio Financial has shown strength after consolidating within a defined range and forming a solid base, indicating steady accumulation and improving demand.

Top stocks in news: Nephrocare, RIL, Park Medi, Akzo Nobel, IOB, Vedanta, NBCC, Ola, RVNL

Dec 17, 2025, 06:57 AM IST

Stocks including Nephrocare, Reliance, Park Medi, Akzo Nobel, Indian Overseas Bank, Vedanta, NBCC, Ola Electric, RVNL, Zaggle Prepaid and more will be in the spotlight on Wednesday, December 17.

Top stocks in news: Ivalue, Polycab, Tata Steel, YES Bank, Lupin, Waaree Energies, IHCL

Sep 25, 2025, 07:55 AM IST

Stocks like Ivalue Infosolutions, Polycab, Tata Steel, YES Bank, Lupin, Waaree Energies, Indian Hotels, Glenmark Pharma and more will be in the spotlight on Thursday, September 25.

Glenmark Pharma shares rise 3% as arm receives $700 mn, more details

Sep 09, 2025, 12:01 PM IST

Glenmark Pharmaceuticals shares climbed 3% to Rs 2,117.95 on BSE today. Market cap of the firm rose to Rs 59,574 crore.

Tata Motors, Adani Ports, Glenmark: What KKunal V Parar of Choice Broking says on them

Sep 04, 2025, 07:42 AM IST

An analyst from Choice Broking said that Adani Ports has been moving in a range-bound pattern on the daily charts, reflecting the absence of a decisive short-term trend.

Book profits in BHEL, Glenmark Pharma & Canara Bank shares, suggests Anand Rathi

Jul 15, 2025, 07:19 AM IST

An analyst from Anand Rathi said that BHEL is encountering strong resistance in the Rs 265–270 zone, which coincides with its previous historical top and marks a critical supply area.

Top stocks in news: TCS, HUL, Glenmark Pharma, IREDA, Tata Elxsi, AR Wealth, Birla Corp, ZEEL

Jul 11, 2025, 07:20 AM IST

Stocks including TCS, Hindustan Unilever, Glenmark Pharma, IREDA, Tata Elxsi, Anand Rathi Wealth, Birla Corp, Zee Entertainment and more will be in the spotlight on Friday, July 11.

Buy Glenmark Pharma, Max Healthcare & Valor Estate shares, suggests Axis Securities

Jun 16, 2025, 07:17 AM IST

An analyst from Axis Securities said that Max Healthcare has delivered a strong breakout from its consolidation range on the weekly charts, confirmed by a robust bullish candle, signalling the continuation of uptrend.

Glenmark Pharma: Nomura retains 'Neutral' stance, sets targets at Rs 1,500

May 26, 2025, 09:14 AM IST

Glenmark Pharma launched 13 new products in FY25, including seven in the fourth quarter, along with receiving five ANDA approvals